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Introduction
Oats are rich source of non-starch polysaccharides 
(NSP) (4.5 g/100 g); furthermore, 58% of the total 
NSP are soluble, which is higher than in all the other 
cereals (Miller and Fulcher 2011). The main compo-
nent of soluble NSP of oats is (1/3), (1/4)-b-D-glu-
can (referred as β-glucan). Oats contains 3.2–6.8% 
β-glucan, which varies with cultivar and environmental 
effects (Holguin-Acun et al. 2011).
The largest tissue in all of the cereal grains is the 
endosperm, which may constitute up to 70% of the 
weight of the mature oat groat (Miller and Fulcher 
2011). The fractionation characteristics of isolated 
endosperm cell wall suggested a layer model: a relatively 
thin outer layer, consisting of an insoluble polysaccha-
ride skeleton (mostly cellulose, glucomannan, and ara-
binoxylan) and matrix polysaccharides (β-glucan and 
arabinoxylan), and also a large inner layer of soluble 
polysaccharides (mostly β-glucan and small amount of 
arabinoxylan (Miller and Fulcher 2011).
The cell walls of subaleurone layer of some oat varie-
ties can be very thick. This is an important structural 
feature allowing production of bran fractions with high 
β-glucan content (Kaletunc and Breslauer 2003).
Some NSP are defined as prebiotics, which are 
non-viable food ingredients that can be fermented 
by specific enzymes derived from gut anaerobic bac-
teria (Roberfroid 2007). As a result, prebiotics induce 
the growth or activity of beneficial intestinal bac- 
teria – probiotics, which produce short-chain fatty acids 
(SCFA). The SCFA are natural ligands for free fatty 
acid receptor 2 and 3 (FFAR 2/3), found in enteroendo-
crine and immune cells (Morrison and Preston 2016). 
Consequently, probiotics and prebiotics are widely 
used in human and animal nutrition because they 
beneficially influence the host intestinal microbiota and 
metabolic health.
Most probiotic strains belong to the genus Lacto­
bacillus or Bifidobacterium, with only a few belonging 
to Enterococcus, Escherichia, or Streptococcus (Ulsemer 
et al. 2012).
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A b s t r a c t
Prebiotics inducing the growth or activity of beneficial intestinal bacteria – probiotics producing short-chain fatty acids (SCFA) have lately 
received wide recognition for their beneficial influence on host intestinal microbiota and metabolic health. Some non-starch polysaccha-
rides (NSP) are defined as prebiotics and oats being one of richest sources of NSP in grains are considered as potentially having prebiotic 
effect. However, information on fermentation of specific NSP of oats is limited. Moreover, bacterial cross-feeding interactions in which 
fermentation of prebiotics is involved is poorly characterized. Here, we report the exploration of new candidates for the syntrophic bacterial 
interactions and fermentability of oat non-starch polysaccharides (NSP). The results obtained by differentiating composition, viscosity and 
concentration of oats NSP in fermentation medium showed that Bacillus licheniformis pre-digests oat NSP, degrades high viscosity of oat 
β-glucan and makes hemicellulose easier to access for other bacteria. Because of fermentation, B. licheniformis produces lactic and succinic 
acids, which further can be used by other bacteria for cross-feeding and SCFA production.
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The purpose of the current study was to characterize 
the syntrophic bacterial interaction and fermentability 
of both types of oat NSP: with β-glucan (BG25) or with-
out β-glucan (BG0) by less studied bacterial consortia. 
New candidates for the probiotics: Bacillus licheniformis 
(McFarlin et al. 2017), Clostridium butyricum (Kanai 
et al. 2015) and Bacteroides ovatus (Martín et al. 2013) 
have been explored.
C. butyricum is a common human and animal 
strictly anaerobe, Gram-positive, gut commensal bac-
terium frequently found in the environment (Montoya 
et al. 2001). Some Clostridium strains can secrete α- or 
β-glucanase to degrade polysaccharides (Montoya et al. 
2001; Nakajima et al. 2002). Recent studies in animal 
diabetic models showed positive effects of C. butyri­
cum (Sun et al. 2016; Jia, et al. 2017), which could act 
as a beneficial probiotic for prevention and treatment 
of hyperglycaemia and associated metabolic dysfunc-
tion (Jia et al. 2017).
B. ovatus is also commonly found in mammalian 
intestine (Rajilić-Stojanović and de Vos 2014), the 
genus Bacteroides accounts for up to 40% of human 
colonic microbiota (Hong et al. 2008).
Most recent study discovered a naturally evolved 
cooperation between B. ovatus and B. vulgatus within 
the mammalian intestinal microbiota (Rakoff-Nahoum 
et al. 2016). A cross-feeding enzymes’ system in the gut 
symbiont B. ovatus digests polysaccharides at a cost to 
itself but at a benefit to another species, such as B. vulg­
atus (Rakoff-Nahoum et al. 2016). Furthermore, recent 
genetically engineered B. ovatus showed a significant 
prophylactic effect, limiting the development of intes-
tinal inflammation both clinically and histopathologi-
cally (Hamady 2013).
In other studies in humans, the probiotic poten-
tial of B. licheniformis was identified, which was safe 
and effective for the treatment of diarrhea (Heo et al. 
2014). Moreover, a short-term complex probiotic sup-
plementation including B. licheniformis spores resulted 
in decreasing of dietary endotoxemia, the level of 
tri glycerides, and potentially systemic inflammation 
(McFarlin et al. 2017). However, authors do not explain 
the nature of these results, where microbiota and SCFA 
as ligands for FFAR molecules might be involved.
Although it was reported that spores of B. licheni­
formis cause spoilage of milk, dairy products and bread 
(Pepe et al. 2003; Gopal et al. 2015), the latest study 
has shown that antimicrobial substances secreted by 
B. licheniformis may serve as useful templates for the 
development of food preservative agents of natural ori-
gin (Arbsuwan et al. 2017).
From the foregoing, it is clear that in the last decade 
interest in a new probiotic and prebiotic supplementa-
tion of human diets has increased due to its co-meta-
bolic interactions between gut microbiota and the host. 
However, knowledge of the syntrophic fermentation of 
various oat fractions is still limited, and therefore the 
present study for the first time considered the ferment-




Plant Material and Sample Preparation. Oat 
(Avena sativa) flakes were obtained from the “Rigas 
Dzirnavnieks” Ltd., Latvia. The flakes were milled and 
sieved through the 0.5 mm sieve. The milled flakes 
(50 g) were added to glass beaker filled with 500 ml of 
water (7°C) and mixed by an automatic mixer (Over-
head Stirrer Multi Mixer MM-1000, Biosan, Latvia) for 
30 min at 120 rpm. The solution was washed through 
a 160-µm sieve, then residue on sieve was added into 
beaker filled with 500 ml to repeat washing-sieving 
process, and to remove any water-soluble compounds 
(starch, proteins, low molecular weight β-glucan). The 
residue on sieve was weighted and dried for 4 hours at 
60°C in an oven. 
To prepare the sample free of β-glucan (BG0), the 
above-mentioned ready-made 50 g of substrate with 
a  moisture of 7–9%, containing 25% (1,3;1,4)-β-D-
glucan (BG25) was dissolved in 200 ml of water. Enzy-
matic hydrolysis of β-D-glucan to glucose and low 
molecular weight particles was performed using 0.1% 
β-glucanase with enzymatic activity ≥ 2 000 000 U/ml 
(Sunson Industry Group Co. Ltd., China). Hydrolysis 
was carried out for 90 minutes at 48–52°C, pH 5.3–5.5.
The resulting hydrolysate was cooled to a tem-
perature of 20–25°C. The insoluble fraction of hydro-
lysate and supernatant containing β-D-glucan were 
separated by decantation process. The insoluble part 
of hydrolysate was centrifuged at 5000 rpm for 5 min-
utes (Thermo Scientific Heraeus X3). The resulting 
insoluble fraction of substrate was added to glass 
beaker filled with 500 ml of water (7°C) and washed 
through a 160 µm sieve, then washing-sieving process 
was repeated. Residue was dried at a temperature of 
45–50°C until moisture of 7–9%. The resulting substrate 
further was used as BG0 sample.
Both oat substrates were analyzed for β-glucan con-
tent, which was determined by the specific enzymatic 
method (McCleary and Glennie-Holmes 1985) using 
a mixed-glucan linkage kit (Megazyme Int. Ireland Ltd. 
Wicklow, Irland).
Viscosity Measurement. Viscosity of the solu-
tions containing 1% β-glucan and 0% β-glucan were 
measured before and after batch pasteurization process 
using a digital rotational viscometer equipped with 
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Pt100 temperature sensor (Thermo Scientific HAAKE 
Rotational 7 Plus Viscometer). L1 spindle was used 
to measure dynamic of viscosity. 2.5  grams of BG25 
and 2  grams of BG0 were separately mixed with 
50 ml of water (20°C) at the room temperature (23°C). 
Solutions were placed into 100 ml 5 cm diameter glass 
beakers and gently mixed for 30  seconds, and then 
heated to 60°C. 
Since the viscosity of the solution containing 1% 
β-glucan varied with its temperature (heating/cool-
ing), different calibration geometries were chosen. After 
heating it up to 60°C and during its cooling to 40°C 
30 rpm/range 200 mPas was chosen. Then, the viscosity 
reached upper viscosity limit of the selected calibra-
tion geometry, the calibration settings were changed 
to 12 rpm/500 mPas. After pasteurization, calibration 
parameters of 100 rpm/60 mPas were selected. 
To measure the viscosity of solutions containing 
BG0 prior to the pasteurization process and, the vis- 
cosity of solutions containing BG0 and BG25 after 
the pasteurization process, calibration settings of 
100 rpm/60 mPas were selected. All viscosity measure-
ments were conducted in triplicates.
Growth Medium. Bacterial fermentation of oat NSP 
was conducted in a complex growth medium, which 
contained 10 g/l beef extract (BBLTM beef extract 
powder, Becton Dickinson and Co.), 10 g/l peptone 
(BactoTM peptone, Becton Dickinson and Co.), 5 g/l 
sodium chloride, 3 g/l sodium citrate, 3 g/l yeast extract 
(Powdered purified yeast autolysate for bacteriology, 
Bio-Rad, France), 0.25 g/l L-cysteine (sterile filtered 
and added after a process of batch pasteurization of 
the growth medium), all dissolved in distilled water. 
BG25 as carbon source was added into borosilicate 
jar with 50 ml growth medium to obtain 1% β-glucan 
concentration (2.5 g/50 ml). Such growth medium was 
prepared separately for C. butyricum and B. ovatus. The 
same procedure was carried out for the BG0 (2 g/50 ml). 
To achieve the required level of sterility, a low tem-
perature batch pasteurization method was used. Tightly 
sealed bottled samples were pasteurized in a  water 
batch (fryer filled with water) at 80°C for 30 min and 
then stored at room temperature for repeated conti-
nuous process for 7 days.
To determine the level of sterility/contamination of 
growth medium after pasteurization, 0.1 ml of samples 
were inoculated on R2A medium (Becton & Dickin-
son). After 48 hours, bacterial colonies were identified 
using a commercial biochemical identification kit (BD 
Diagnostic Systems, Sparks, MD). An aliquot of 1 ml 
samples of media was transferred to Eppendorf centri-
fuge tubes and centrifuged at 5000 rpm for 4 minutes 
(Sigma, Germany). A 0.5 ml of supernatant was taken 
and diluted with 0.5 ml acetonitrile (ratio 1:1) and fro-
zen at –18°C for further SCFA detection.
The initial pH of the growth medium and pH after 
24, 72 and 96 hours of the incubation period of bacteria 
was measured using a pH meter (AD I 405).
Bacterial Strains and in vitro Fermentation. The 
bacterial strains used in this study were C. butyricum 
MSCL 1019 and B. ovatus MSCL 841, obtained from 
the Microbial Strain Collection of Latvia, where they 
were stored in liquid nitrogen. Before use, the strains 
were cultivated in Wilkins-Chalgren anaerobe agar 
(Oxoid, UK) under anaerobic conditions (GasPak 
Anaerobic Pouch, Becton & Dickinson) at 37°C for 
48 hours. The harvested strains were adjusted for each 
growth medium to 4.8 × 105 CFU/ml for C. butyricum 
and 2.2 × 105 CFU/ml for B. ovatus. The growth media 
with bacterial strains were incubated in a thermostat 
at 37°C. In vitro fermentation was carried for 96 hours 
under anaerobic conditions. The SCFA concentration 
and pH were measured at 0, 24, 72, 96 hours. Aliquots 
of 1 mL samples were transferred to Eppendorf centri-
fuge tubes and centrifuged at 5000 rpm for 4 minutes 
(Sigma 1-14, Germany). A 0.5 ml of supernatant was 
taken and diluted with 0.5 ml acetonitrile (ratio 1:1). 
All samples were done at duplicates and were frozen at 
–18°C for further SCFA analysis.
SCFA Analysis by LC-TOF-MS. Concentrations 
of SCFA were determined by liquid chromatography 
time-of-flight mass spectrometry (LC-TOF-MS) in 
accordance with previously described analytical meth-
ods (Ferrer and Thurman 2003; Ibanez and Bauer 
2014; Han et al. 2015). All solvents were of analytical 
grade. Formic acid was purchased from Sigma-Aldrich 
(St. Louis, USA). Deionized water (18.2 MΩ) was pre-
pared by a Milli-Q water purification system from 
Millipore (Billerica, Massachusetts, USA). LC analy-
ses were performed using Agilent 1290 Infinity series 
(Agilent Technologies, Germany) UHPLC equipped 
with an Agilent 1290 DAD photodiode array detector. 
Phenomenex (Torrance, CA) RezexTM ROA-Organic 
(Acid H+ (8%) (250 mm × 4.6 mm) column was 
employed for the separation. The column was thermo-
stated at 55 ± 1°C. The injection volume was 2.0 µL.
The mobile phase was directly on-line degassed 
and its composition consisted of 0.5% (v/v) formic 
acid in water at a flow rate of 0.30 ml/min in isocratic 
mode. The high-resolution mass spectra (HRMS) were 
taken on an Agilent 6230 TOF LC/MS system (Agilent 
Technologies, Germany) with electrospray ionization 
(ESI). The source parameters were: negative ionization 
mode, drying gas flow 10.0 l/min and temperature 
285°C, fragmentor ionisation 75 V. One full mass spec-
trum was acquired in a profile mode, with mass range 
from m/z 50 to 1100, 1 scan/s. The data of SCFA were 
obtained using the extraction of individual compound 
chromatogram at its individual m/z value. The internal 
reference masses of m/z 112.9856 and m/z 1033.9881 
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(G1969-85001 ESI-TOF Reference Mass Solution Kit, 
Agilent Technologies & Supelco) were used for all 
analyses of the samples. The experimental data were 
handled using the MassHunter version B07.00 software 
(Agilent Technologies). 
Data Processing and Analysis. Identification of 
separated SCFA were based on the search for [M-H]-
ions, using extracted ion mass chromatograms. 
The experimentally obtained mass spectra of SCFA 
approved the calculated values (lactic acid C3H6O3, 
[M-H]- Calculated – 89.0264, Found – 89.0244, 
Δ 0.0020; acetic acid C2H4O2, [M-H]-Calculated 
–  59.0150, Found – 59.0139, Δ 0.0011; succinic acid 
C4H6O4, [M-H]-Calculated – 117.0217, Found 
– 117.0193, Δ 0.0024; propionic acid C3H6O2, [M-H]- 
Calculated – 73.0303, Found – 73.0295, Δ 0.0008; 
butyric acid C4H8O2, [M-H]-Calculated – 87.0114, 
Found – 87.0452, Δ 0.0338). For quantification the 
calibration curves of acetic, propionic, succinic and 
lactic acids, the standard solutions were constructed 
by plotting the ratio of the average chromatographic 
peak area and mass concentration. According to the 
reflected data, the regression equation of the trend line 
was calculated. Standard solutions were injected in trip-
licate, and the corresponding peak areas were recorded. 
The relative standard deviation between all solutions 
was determined to be less than 1.5%. The calibration 
curves obtained showed linearity of the determination 
coefficient (R2 > 0.99) in the used concentration range 
(0.5–100 µg/ml). A coefficient of determination (R2) 
was calculated using Microsoft Excel 2013, p < 0.001. 
Analyses of SCFA measurements done at duplicates 
were averaged. To compare the means between vis- 
cosity measurements one-way analysis of variance 
(one-way ANOVA) was used, p value of less than 0.05 
was considered significant. Data were expressed in 
µg/ml as means ± S.D.
Results and Discussion
The results of our study showed that the batch pas-
teurization of solutions with oat NSP did not inacti-
vate the thermostable B. licheniformis (biotype valid-
ity 18185, confidence 0.9555). Since B. licheniformis is 
а source of β-1,3-1,4-glucanase (Planas 2000) its effect 
on β-glucan viscosity degradation and SCFA produc-
tion by the bacteria alone and in consortium with 
C. butyricum and B. ovatus was further tested. 
The viscosity of a solution containing 1% β-glucan 
before the pasteurization process, directly after mixing 
prepared substrate with water (20°C), was 14 ± 1 mPas 
(pH 6.9). After the solution was heated to 60°C and 
then cooled to room temperature, there was а tendency 
to increase the viscosity (Fig. 1).
The final stable viscosity after cooling the solu-
tion to room temperature reached 260 mPas (Fig. 1). 
At the end of the pasteurization process, the viscosity 
of the solution containing BG25, degraded by B. liche­
niformis decreased to 4 ± 1 mPas and did not differ 
from the solution containing BG0, in which β-glucan 
was degraded using commercial enzymes (2 ± 1 mPas 
vs 4 ± 1 mPas, p = 0.18). 
Oat β-glucan is able to form highly viscous solutions 
at low concentrations; however, the viscosity depends 
on the concentration and the molecular weight of 
β-glucan (Anttila et al. 2008). 
Our results showed that fermentation of oat 
β-glucan by B. licheniformis resulted in degradation 
of β-glucan viscosity and, consequently, its molecular 
weight. As noted earlier (Sahasrabudhe et al. 2016), 
the enzymatic degradation of medium viscosity of oat 
β-glucan enhances its effect on immune receptors. The 
digested oat β-glucan activates type II transmembrane 
protein receptor Dectin-1 that binds β-1,3- and β-1,6-
glucans more efficiently than non-digested β-glucan 
Fig. 1. Changes in the viscosity of a solution containing 1% oat β-glucan, after heating it up to 60°C
and cooling to room temperature. Data represent mean ± SD of triplicates.
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(Sahasrabudhe et al. 2016). In this way, pre-digestion 
of high molecular weight of oat β-glucan by B. licheni­
formis may have more visible host’s microbial-inde-
pendent immune modulation effects in vivo through 
the pattern-recognition receptor Dectin-1 activation, 
what should be explored in future.
After pasteurizing of the growth medium containing 
B. licheniformis, lactic acid was detected in both BG25 
(14.8 µg/ml) and BG0 (15.6 µg/ml), and also succinic 
acid at a concentration of 11.4 µg/ml in BG25 and 
12.7 µg/ml in BG0, respectively. Propionic and butyric 
acids have not been detected in any of the growth media 
(BG25 and BG0), indicating that B. licheniformis does 
not have the potential to produce these SCFA. A very 
low concentration of acetic acid (1.8 µg/ml) produced 
by B. licheniformis was detected in BG0.
After B. ovatus was added to the growth medium 
containing B. licheniformis, the lactic acid concentra-
tion decreased in both BG25 and BG0 after 24 hours 
(Fig. 2A). Succinic acid decreased in BG0 after 24 hours 
period, but not in BG25 (Fig. 2B). These data show that 
B. ovatus within the 24 hours of fermentation consumed 
lactic and succinic acids produced by B. licheniformis 
(Fig. 2A, 2B). 
Because B. licheniformis produces lactic and succinic 
acids, it could be involved in bacterial cross-feeding 
and butyrate synthesis through the butyril-CoA: acetate 
CoA-transferase pathway (Reichardt et al. 2014), as well 
as in the synthesis of propionate through either succi-
nate synthesis pathway or acrylate pathway using lactate 
(Reichardt et al. 2014).
The concentration of lactic acid, produced by 
B. licheniformis in a consortium with B. ovatus in BG25 
was lower than in BG0 (58.5 vs 27.1 µg/ml after 72 hours 
and 37.5 vs 72.6 µg/ml after 96 hours of fermentation 
for BG25 and BG0 (Fig. 2A). One of the hypotheses that 
explain this finding can be an assumption that degra-
dation of β-glucan by commercial enzymes facilitates 
access to hemicellulose for bacteria. This hypothesis is 
also implied by the fact that the pH value in BG0 was 
lower than in BG25 (Fig. 3A, 3B). 
Since the β-xylosidases from B. ovatus have been 
found to be highly effective in digesting hemicellu-
lose to xylooligosaccharides (Jordan et al. 2017), it is 
Fig. 2. Changes in concentration of lactic (A), succinic (B), butyric (C), propionic (D), and acetic (E) acids within
96 hours of syntrophic in vitro fermentation of BG0 and BG25 by B. licheniformis in the consortium
with C. butyricum and B. ovatus.
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likely that oat hemicelluloses that were not digested by 
B. licheniformis, have been finally degraded by B. ovatus 
into xylooligosaccharides. These xylooligosaccharides 
can become substrates for B. licheniformis through the 
use of xylanase enzymes. As a result, further syntrophic 
fermentation of xylooligosaccharides led to the produc-
tion of lactic and succinic acids by B. licheniformis. 
The results of our study showed that fermentation of 
BG0 and BG25 during culture of the consortium con-
sisted of B. licheniformis and B. ovatus or C. butyricum 
resulted in an increase of the concentration of propionic 
and butyric acids (Fig. 2C, 2D), while the production 
of butyrate and propionate by the same bacterium is 
not common. Only a few anaerobes, such as Roseburia 
inulinivorans and Coprococcus catus were previously 
mentioned having the ability to produce both (Reich-
ardt et al. 2014).
The total acid concentration peak for B. licheniformis 
in consortium with C. butyricum was observed after 
24 hours of fermentation in BG25 and BG0 (Fig. 3C, 
3D). It was assumed that B. licheniformis degraded large 
β-glucan molecules and produced lactic and succinic 
acids, while the simple or/and complex sugars were 
degraded by C. butyricum, because of their previously 
mentioned enzymatic capacities (Montoya et al. 2001; 
Nakajima et al. 2002). 
The acetic acid produced by B. licheniformis in con-
sortium with C. butyricum or B. ovatus did not reach 
3 μg/ml (Fig. 2E), which is the lowest concentration of 
all the acids analysed. 
Because the current study did not consider antago-
nistic interactions between members of the bacterial 
consortium, a further study are needed to investigate 
if B. licheniformis competes for the substrate with other 
bacteria, and thereby reduces availability of the sub-
strate to another bacterium (pathogenic or probiotic).
Conclusions
In conclusion, the results of this study show that 
B. licheniformis, a widespread food contaminant, acts 
as thermostable probiotic that ferments oat NSP. It 
pre-digests oat NSP, degrades the high viscosity of oat 
β-glucan and makes hemicellulose more accessible for 
other bacteria. As a result of fermentation, B. licheni­
formis produces lactic and succinic acids, which further 
can be used by other bacteria for cross-feeding and pro-
duction of SCFA. Thus, B. licheniformis in syntrophic 
consortia with C. butyricum or B. ovatus produces 
SCFA, which were not produced when B. licheniformis 
was grown alone.
Fig. 3. The total acids concentrations and changes in pH within the 96 hours of syntrophic in vitro fermentation
of BG25 (A, C) and BG0 (B, D) by B. ovatus (A, B) and C. butyricum (C, D) in consortium
with B. licheniformis.
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